Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk
“Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk”, vol. 13, pp. 9976-9985, 2014.
, We examined whether the X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism is a risk factor for bladder cancer by conducting a meta-analysis. We searched the Pubmed and Embase databases for study retrieval. This meta-analysis examined 16 case-control studies, including 892 prostate cancer cases and 1020 healthy controls.